Gyroscope Therapeutics Hldgs Ltd (VISN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 41,464 | 52,673 | 54,044 | 115,668 | 0 |
| Cost of Goods | 46,112 | 58,612 | 48,849 | 121,720 | N/A |
| Gross Profit | -4,648 | -5,939 | 5,195 | -6,052 | N/A |
| Operating Expenses | 21,944 | 20,414 | 31,493 | 246,219 | 0 |
| Operating Income | -26,480 | -25,742 | -25,449 | -251,551 | N/A |
| Interest Expense | 5,964 | 4,569 | 1,426 | 2,615 | 0 |
| Other Income | -269 | -124 | -250 | 90 | 0 |
| Pre-tax Income | -32,713 | -30,435 | -27,125 | -254,075 | 0 |
| Income Tax | N/A | 143 | 374 | -7,547 | N/A |
| Net Income Continuous | -32,713 | -30,577 | -27,498 | -246,528 | N/A |
| Net Income Discontinuous | 7,390 | -889 | 3,442 | N/A | N/A |
| Minority Interests | -1,923 | -389 | -89 | -119 | N/A |
| Net Income | $-23,400 | $-31,077 | $-23,968 | $-246,409 | $N/A |
| EPS Basic Total Ops | -4.60 | -6.20 | -4.80 | -48.60 | N/A |
| EPS Basic Continuous Ops | -6.39 | -6.02 | -5.42 | -48.64 | N/A |
| EPS Basic Discontinuous Ops | 1.44 | -0.18 | 0.68 | N/A | N/A |
| EPS Diluted Total Ops | -4.60 | -6.20 | -4.80 | -48.60 | N/A |
| EPS Diluted Continuous Ops | -6.39 | -6.02 | -5.42 | -48.64 | N/A |
| EPS Diluted Discontinuous Ops | 1.44 | -0.18 | 0.68 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -6.01 | -6.12 | -4.30 | -13.28 | -0.60 |
| EBITDA(a) | $-24,558 | $-22,395 | $-21,285 | $-243,779 | $N/A |